Cancer
📧 Sign up to get email alerts when something new happens for Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-06-10Clinical Trial Update: A Study to Evaluate the Hematologic Response Rate (the Rate at Which the Hemoglobin Level Rises) of PROCRIT (Epoetin Alfa) Given at a Dose of 80,000 Units Once Weekly to Cancer Patients With Anemia Who Are Receiving Chemotherapy. [Phase 3]
Phase 3 clinical trial evaluating the hematologic response (hemoglobin increase) to PROCRIT (epoetin alfa) given at 80,000 units weekly in c…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: Palliative Care Study in Patients With Advanced Cancer [Phase 2]
This update notes that a Phase 2 palliative-care study in patients with advanced cancer was terminated. No efficacy or safety results are pr…
-
CLINICAL_TRIALS trial_result · 2011-06-06Clinical Trial Update: Study of Liposome Encapsulated Mitoxantrone (LEM) in Patients With Advanced Cancer [Phase 1]
Phase 1 study assessing liposome-encapsulated mitoxantrone (LEM) in patients with advanced cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2011-05-27Clinical Trial Update: Safety Study of FLP Injection to Treat Tumor Patients [Phase 1]
Phase 1 safety study evaluating FLP injection in patients with cancer.
-
CLINICAL_TRIALS trial_result · 2011-05-26Clinical Trial Update: Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer [NA]
This document reports a terminated clinical trial evaluating epoetin alfa for chemotherapy-related anemia in cancer patients, with results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: Alternate Dosing of PROCRIT (Epoetin Alfa) in Patients With Cancer and Chemotherapy Induced Anemia [Phase 2]
This Phase 2 clinical trial update assesses alternate dosing regimens of epoetin alfa (PROCRIT) in cancer patients with chemotherapy-induced…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Efficacy of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer [Phase 3]
Phase 3 trial evaluating the efficacy of the Fentanyl Transdermal Therapeutic System for cancer-related pain management.
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: Clinical Use and Safety of the Fentanyl Transdermal Therapeutic System (TTS) in the Management of Pain in Patients With Cancer [Phase 3]
A Phase 3 trial update on the safety and clinical use of the Fentanyl Transdermal System for cancer-related pain, with the study status mark…
-
CLINICAL_TRIALS trial_result · 2011-05-19Clinical Trial Update: A Study to Assess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy. [Phase 3]
A Phase 3 study evaluating weekly 40,000 units of epoetin alfa (PROCRIT) in cancer patients with anemia who are not receiving chemotherapy w…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in Patients With Anemia as a Result of Advanced Cancer and Treatment With Aggressive Chemotherapy [Phase 2]
Phase 2 study evaluating the safety and effectiveness of epoetin alfa for treating anemia in patients with advanced cancer undergoing aggres…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: PROCRIT (Epoetin Alfa) 60,000 Units Administered Once Every Two Weeks in Anemic Cancer Patients Who Are Not Receiving Chemotherapy or Radiation Therapy [Phase 2]
Phase 2 trial evaluating epoetin alfa (PROCRIT) 60,000 units given every two weeks in anemic cancer patients not receiving chemotherapy or r…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy [Phase 3]
Phase 3 trial evaluating epoetin alfa for anemia in cancer patients receiving non-platinum chemotherapy has completed. The study was sponsor…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy [Phase 2]
Phase 2 study comparing PROCRIT (epoetin alfa) 80,000 units every four weeks with 40,000 units every two weeks in cancer patients not receiv…
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy [Phase 3]
A Phase 3 trial evaluated the use of granulocyte colony-stimulating factor (G-CSF) to prevent chemotherapy-induced neutropenia in patients w…
-
CLINICAL_TRIALS trial_result · 2011-04-27Clinical Trial Update: Treatment of Anemic Patients With Cancer Who Are Not Receiving Chemotherapy or Radiotherapy [Phase 3]
A Phase 3 trial evaluating a treatment for anemia in cancer patients not receiving chemotherapy or radiotherapy was terminated.
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: A Phase I Study of Oral Ixabepilone in Subjects With Advanced Cancer [Phase 1]
A Phase I study of oral ixabepilone in patients with advanced cancer has completed and results were posted.
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Psychosocial Support for Cancer Patients
A clinical trial evaluating psychosocial support for cancer patients has been completed.
-
CLINICAL_TRIALS trial_result · 2011-04-19Clinical Trial Update: The Effect of Chemotherapy on Lactate Threshold in Cancer Patients
A completed clinical trial evaluating the impact of chemotherapy on lactate threshold in cancer patients.
-
CLINICAL_TRIALS trial_result · 2011-04-18Clinical Trial Update: Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer [Phase 3]
Phase 3 clinical trial evaluating darbepoetin alfa with or without iron for anemia caused by chemotherapy in cancer patients; the study is c…
-
CLINICAL_TRIALS trial_result · 2011-03-29Clinical Trial Update: Efficacy of Caffeine Injection as an Adjuvant to Opioid Therapy in Cancer Pain [Phase 2]
Phase 2 clinical trial evaluating caffeine injection as an adjuvant to opioid therapy for cancer-related pain; results were posted after com…
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: Enteral Nutrition in Cancer Patients [Phase 4]
A Phase 4 clinical trial assessing enteral nutrition in cancer patients with malnutrition has completed. The update notes the study status i…
-
CLINICAL_TRIALS trial_result · 2011-02-24Clinical Trial Update: Enteral Nutrition in Cancer Patient [Phase 4]
Phase 4 trial assessing enteral nutrition in pediatric cancer patients with malnutrition has completed.
-
CLINICAL_TRIALS trial_result · 2011-02-15Clinical Trial Update: Acupuncture for the Treatment of Chronic Post-Chemotherapy Fatigue: A Randomized, Phase III Trial [Phase 3]
A completed randomized Phase III trial evaluating acupuncture for chronic post-chemotherapy fatigue in cancer patients.
-
CLINICAL_TRIALS trial_result · 2011-02-10Clinical Trial Update: Carcinogenicity Study of Bupropion
Completed carcinogenicity study of bupropion with results posted by sponsor GlaxoSmithKline, involving depressive disorder and cancer as con…
-
CLINICAL_TRIALS trial_result · 2011-02-02Clinical Trial Update: Oxycodone and Pregabalin for the Treatment of Oncological Neuropathic Pain [Phase 2]
Phase 2 clinical trial evaluating the combination of oxycodone and pregabalin for oncological (cancer-related) neuropathic pain has complete…